Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly.

Article Details

Citation

Gould DB, Phalan FC, Breedveld GJ, van Mil SE, Smith RS, Schimenti JC, Aguglia U, van der Knaap MS, Heutink P, John SW

Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly.

Science. 2005 May 20;308(5725):1167-71. doi: 10.1126/science.1109418.

PubMed ID
15905400 [ View in PubMed
]
Abstract

Porencephaly is a rare neurological disease, typically manifest in infants, which is characterized by the existence of degenerative cavities in the brain. To investigate the molecular pathogenesis of porencephaly, we studied a mouse mutant that develops porencephaly secondary to focal disruptions of vascular basement membranes. Half of the mutant mice died with cerebral hemorrhage within a day of birth, and approximately 18% of survivors had porencephaly. We show that vascular defects are caused by a semidominant mutation in the procollagen type IV alpha 1 gene (Col4a1) in mice, which inhibits the secretion of mutant and normal type IV collagen. We also show that COL4A1 mutations segregate with porencephaly in human families. Because not all mutant mice develop porencephaly, we propose that Col4a1 mutations conspire with environmental trauma in causing the disease.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Collagen alpha-1(IV) chainP02462Details